826 related articles for article (PubMed ID: 10946879)
1. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
2. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
Toscano V; Bianchi P; Balducci R; Guglielmi R; Mangiantini A; Lubrano C; Sciarra F
Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
[TBL] [Abstract][Full Text] [Related]
3. Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome.
Nestler JE; Barlascini CO; Matt DW; Steingold KA; Plymate SR; Clore JN; Blackard WG
J Clin Endocrinol Metab; 1989 Jun; 68(6):1027-32. PubMed ID: 2498378
[TBL] [Abstract][Full Text] [Related]
4. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome.
Nestler JE; Powers LP; Matt DW; Steingold KA; Plymate SR; Rittmaster RS; Clore JN; Blackard WG
J Clin Endocrinol Metab; 1991 Jan; 72(1):83-9. PubMed ID: 1898744
[TBL] [Abstract][Full Text] [Related]
5. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss.
Pasquali R; Antenucci D; Casimirri F; Venturoli S; Paradisi R; Fabbri R; Balestra V; Melchionda N; Barbara L
J Clin Endocrinol Metab; 1989 Jan; 68(1):173-9. PubMed ID: 2642485
[TBL] [Abstract][Full Text] [Related]
6. The role of nutrition and insulin in the regulation of sex hormone binding globulin.
Franks S; Kiddy DS; Hamilton-Fairley D; Bush A; Sharp PS; Reed MJ
J Steroid Biochem Mol Biol; 1991 Nov; 39(5B):835-8. PubMed ID: 1954173
[TBL] [Abstract][Full Text] [Related]
7. Effects and plasma proteomic analysis of GLP-1RA versus CPA/EE, in combination with metformin, on overweight PCOS women: a randomized controlled trial.
Liao M; Li X; Zhang H; Zhou L; Shi L; Li W; Shen R; Peng G; Zhao H; Shao J; Wang X; Sun Z; Zheng H; Long M
Endocrine; 2024 Jan; 83(1):227-241. PubMed ID: 37653215
[TBL] [Abstract][Full Text] [Related]
8. Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations.
Dale PO; Tanbo T; Vaaler S; Abyholm T
Fertil Steril; 1992 Sep; 58(3):487-91. PubMed ID: 1521640
[TBL] [Abstract][Full Text] [Related]
9. Insulin and insulin-like growth factor-I responsiveness in polycystic ovarian syndrome.
Buyalos RP; Geffner ME; Bersch N; Judd HL; Watanabe RM; Bergman RN; Golde DW
Fertil Steril; 1992 Apr; 57(4):796-803. PubMed ID: 1555690
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Oligopin Supplementation on Hormonal and Metabolic Profiles in the Polycystic Ovary Syndrome: A Randomized Controlled Trial.
Qorbani M; Sanginabadi M; Mohajeri-Tehrani MR; Karimi S; Gerami H; Mahdavi-Gorabi A; Shirzad N; Samadi M; Baygi F; Hosseini S; Mansour A
Front Endocrinol (Lausanne); 2020; 11():590392. PubMed ID: 33408691
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of combined simvastatin and metformin treatment on the clinical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome.
Seyam E; Hefzy E
Gynecol Endocrinol; 2018 Dec; 34(12):1073-1080. PubMed ID: 30044162
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease.
Anttila L; Ding YQ; Ruutiainen K; Erkkola R; Irjala K; Huhtaniemi I
Fertil Steril; 1991 Jun; 55(6):1057-61. PubMed ID: 1903726
[TBL] [Abstract][Full Text] [Related]
13. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome.
Kiddy DS; Hamilton-Fairley D; Bush A; Short F; Anyaoku V; Reed MJ; Franks S
Clin Endocrinol (Oxf); 1992 Jan; 36(1):105-11. PubMed ID: 1559293
[TBL] [Abstract][Full Text] [Related]
14. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases.
Kiddy DS; Sharp PS; White DM; Scanlon MF; Mason HD; Bray CS; Polson DW; Reed MJ; Franks S
Clin Endocrinol (Oxf); 1990 Feb; 32(2):213-20. PubMed ID: 2112067
[TBL] [Abstract][Full Text] [Related]
15. Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome.
Sharp PS; Kiddy DS; Reed MJ; Anyaoku V; Johnston DG; Franks S
Clin Endocrinol (Oxf); 1991 Sep; 35(3):253-7. PubMed ID: 1742883
[TBL] [Abstract][Full Text] [Related]
16. The relative contribution of androgens and insulin in determining abdominal body fat distribution in premenopausal women.
Pasquali R; Casimirri F; Balestra V; Flamia R; Melchionda N; Fabbri R; Barbara L
J Endocrinol Invest; 1991 Nov; 14(10):839-46. PubMed ID: 1802922
[TBL] [Abstract][Full Text] [Related]
17. Association of Macronutrients Composition, Physical Activity and Serum Androgen Concentration in Young Women with Polycystic Ovary Syndrome.
Mizgier M; Watrowski R; Opydo-Szymaczek J; Jodłowska-Siewert E; Lombardi G; Kędzia W; Jarząbek-Bielecka G
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010948
[TBL] [Abstract][Full Text] [Related]
18. Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women.
Falcone T; Finegood DT; Fantus IG; Morris D
J Clin Endocrinol Metab; 1990 Dec; 71(6):1653-7. PubMed ID: 2146285
[TBL] [Abstract][Full Text] [Related]
19. Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome.
González F; Sia CL; Stanczyk FZ; Blair HE; Krupa ME
Endocrine; 2012 Dec; 42(3):726-35. PubMed ID: 22752961
[TBL] [Abstract][Full Text] [Related]
20. The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria.
Pustotina O; Myers SH; Unfer V; Rasulova I
Gynecol Obstet Invest; 2024; 89(2):131-139. PubMed ID: 38295772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]